Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases

The Centers for Disease Control and Prevention (CDC), through its Office of Extramural Research and Awards (ERA), is announcing a forecasted funding opportunity titled “Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases.” This cooperative agreement is administered under the Assistance Listing Number 93.860, which supports Emerging Infections Sentinel Networks. The primary objective of this grant opportunity is to strengthen public health systems and preparedness by funding a collaborative research network that focuses on travel-associated infectious diseases. The CDC is a federal agency dedicated to protecting public health through disease prevention and control, environmental health, and health education. The purpose of this funding opportunity is to support research projects that enhance surveillance capabilities, early detection, and effective management strategies for travel-related infectious illnesses. Specifically, the program seeks to build a robust network of travel and tropical medicine providers engaged in research and disease surveillance. Through this coordinated effort, the CDC aims to produce actionable data that supports the development of guidelines and recommendations, improves diagnostics and treatment protocols, and strengthens the overall global health security infrastructure of the United States. The program emphasizes the importance of sentinel event detection and rapid response capabilities to prevent the spread of infectious diseases both domestically and internationally. The anticipated funding scope includes one cooperative agreement award with an estimated total program funding of $3,000,000. Individual award amounts are expected to range between $450,000 and $600,000. Allowable spending under this funding opportunity will focus on research implementation, data analysis, network building, dissemination of findings, and other related public health activities directly tied to travel-associated infections. While the opportunity is significant in scale, cost sharing or matching is not required for participation. Eligible applicants for this opportunity include a wide variety of entities, such as state and local governments, Native American tribal governments and organizations, public and private institutions of higher education, public housing authorities, nonprofits with or without 501(c)(3) status, independent school districts, and for-profit organizations (excluding small businesses). There are no geographic limitations; applicants from all U.S. states are eligible to apply. The broad eligibility criteria aim to foster cross-sectoral collaboration and ensure diverse participation in addressing global health threats. As a forecasted opportunity, the funding announcement was posted on August 1, 2025, with an estimated application open date of December 31, 2025. Applications will be due by March 1, 2026, no later than 11:59 p.m. Eastern Time. The estimated award date is August 15, 2026, and the proposed project start date is September 1, 2026. The archive date for this forecast is listed as March 31, 2026, indicating the last date the opportunity will remain available for public reference. For any inquiries regarding this funding opportunity, interested applicants may contact Amy Yang at 404-718-8836 or via email at AYang@cdc.gov. This opportunity represents a strategic investment by the CDC in reinforcing national and international public health systems, particularly in mitigating the impact of travel-associated infectious diseases. Potential applicants should begin preparing now to take full advantage of the resources and collaborative framework offered through this initiative.